ZusammenfassungDie SARS-CoV-2-Pandemie führte bei einer Mitte 60-jährigen Patientin zu vermehrten Symptomen einer bisher undiagnostizierten wahnhaften Störung und schließlich zu einem Suizidversuch. Aufgrund der Pandemie mit spür- und sichtbaren gesellschaftlichen Veränderungen können Menschen mit bislang subklinischen psychotischen Erkrankungen erstmals mit psychiatrischen Versorgungsangeboten in Kontakt kommen. Trotz fehlender Krankheitseinsicht und Ablehnung einer medikamentösen Therapie gelangen ein therapeutischer Beziehungsaufbau sowie eine tragfähige Vermittlung in ambulante Behandlungsangebote.

BackgroundRecent guidelines recommend a cranial ultrasound (CU) in neonates born at < 30 weeks gestation, admitted to the neonatal intensive care unit (NICU), or with a CU indication. Here, we addressed the need to extend these recommendations.MethodsWe retrospectively reviewed 5107 CUs acquired in the population-based Survey of Neonates in Pomerania, conducted in 2002 to 2008. Neonates with conspicuous CUs that were ≥ 30 weeks gestation without recent indications for CU were identified and assigned to the following groups: with (I) or without (II) admission to neonatal care. We designated CU conspicuities as mild (MC) or significant (SC), and we investigated related neurodevelopment during follow-up.ResultsOf 5107 neonates, 5064 were born at ≥30 weeks gestation and of those, 4306 received CUs without any indication for this examination. We found conspicuities in 7.7% (n = 47/610) of group I (n = 30 MC, n = 17 SC), and 3.2% (n = 117/3696) of group II (n = 100 MC, n = 17 SC). In group II, SC comprised, e.g., bilateral cysts, partial agenesis of the corpus callosum, and periventricular leukomalacia. Follow-up was available in 75% of infants in group II with MCs and SCs; of these, 12.8% had an abnormal neurological follow-up.ConclusionsWe detected a high number of conspicuities in neonates without a CU indication. However, we could not demonstrate that ultrasound findings were associated with the neurological follow-up or any advantage to an earlier diagnosis. Our data did not support extending current guidelines or a general CU screening policy for all neonates.

No abstract

No abstract